BioSpace News Archive

Owlstone Medical Announces Advancements in Breath Biopsy Platform Including Launch of Next Generation ReCIVA Breath Sampler and CASPER Portable Air Supply

Owlstone Medical announced the introduction of a new ReCIVA® Breath Sampler and CASPERTM Portable Air Supply, designed to support internal biomarker discovery programs and those of academic and biopharma clients, and to measure levels of known volatile organic compounds on breath.

September 5, 2019
·
4 min read
Genetown

Summit Presented In Vivo Proof of Concept Data for Targeted Enterobacteriaceae Antibiotics at ASM/ESCMID Conference

Summit Therapeutics plc presented in vivo proof of concept data for its targeted Enterobacteriaceae antibiotics in animal models of sepsis, pneumonia and urinary tract infection.

September 5, 2019
·
7 min read
Job Trends

Bristol-Meyers Squibb, Boehringer Ingelheim and Other Biotechnology Companies to Present Use of Carterra’s Next Generation Antibody Screening Technology at Symposia Across the US and Europe

The Therapeutic Antibody Revolution in the Post Genomics Era: Using High Throughput SPR to Explore the Full Kinetic and Epitope Diversity of Antibody Libraries Supporting mAb, CAR-T, Bispecifics and ADC Therapeutic Discovery

September 5, 2019
·
3 min read
BioMidwest

Esperion Completes Patient Enrollment in the Global CLEAR Cardiovascular Outcomes Trial for Bempedoic Acid

Esperion announced the completion of patient enrollment in the CLEAR Cardiovascular Outcomes Trial.

September 5, 2019
·
9 min read
Policy

GBT Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Voxelotor for the Treatment of Sickle Cell Disease

Global Blood Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company’s New Drug Application (NDA) seeking accelerated approval for voxelotor, an oral, once-daily therapy in development for the treatment of sickle cell disease (SCD).

September 5, 2019
·
8 min read